Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type 2 diabetes mellitus

Cytochrome P450 2C9 2 and 3 polymorphisms and the dose and effect of sulfonylurea in type 2 diabetes mellitus

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	S154-S154
Journal	Pharmacoepidemiology and Drug Safety
Volume	16
Publication status	Published - 2007

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{54c365b078d7409a8b49201d07f3c15e,

title = "Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type 2 diabetes mellitus",

author = "Matthijs Becker and Loes Visser and PH Trienekens and Bert Hofman and {van Schaik}, Ron and Bruno Stricker",

year = "2007",

language = "Undefined/Unknown",

volume = "16",

pages = "S154--S154",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley & Sons Ltd.",

}

TY - JOUR

T1 - Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type 2 diabetes mellitus

AU - Becker, Matthijs

AU - Visser, Loes

AU - Trienekens, PH

AU - Hofman, Bert

AU - van Schaik, Ron

AU - Stricker, Bruno

PY - 2007

Y1 - 2007

M3 - Article

SN - 1053-8569

VL - 16

SP - S154-S154

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

ER -